
Brand Name | Status | Last Update |
|---|---|---|
| fluorodopa | New Drug Application | 2021-01-15 |
Expiration | Code | ||
|---|---|---|---|
FLUORODOPA F-18, FLUORODOPA F18, FEINSTEIN | |||
| 2024-10-10 | NCE, W | ||

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Prostatic neoplasms | D011471 | — | C61 | 48 | 62 | 36 | 9 | 97 | 235 |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 69 | 51 | 22 | 8 | 71 | 211 |
| Neoplasms | D009369 | — | C80 | 69 | 35 | 3 | 3 | 85 | 185 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 44 | 38 | 6 | 5 | 68 | 157 |
| Non-small-cell lung carcinoma | D002289 | — | — | 19 | 24 | 6 | 1 | 38 | 82 |
| Brain neoplasms | D001932 | EFO_0003833 | C71 | 23 | 21 | 4 | 2 | 31 | 77 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | 22 | 21 | 6 | 1 | 31 | 76 |
| Lung neoplasms | D008175 | — | C34.90 | 17 | 15 | 7 | 2 | 37 | 72 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 9 | 6 | 2 | 1 | 24 | 42 |
| Positron-emission tomography | D049268 | — | — | 4 | 2 | 1 | 1 | 34 | 40 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 59 | 8 | 2 | — | 13 | 81 |
| Cognitive dysfunction | D060825 | — | G31.84 | 11 | 23 | 6 | — | 34 | 72 |
| Glioma | D005910 | EFO_0000520 | — | 18 | 8 | 2 | — | 28 | 55 |
| Squamous cell carcinoma of head and neck | D000077195 | — | — | 19 | 14 | 2 | — | 14 | 45 |
| Dementia | D003704 | EFO_0003862 | F03 | 8 | 10 | 4 | — | 27 | 45 |
| Renal cell carcinoma | D002292 | EFO_0000376 | — | 15 | 15 | 1 | — | 15 | 39 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | 8 | 9 | 1 | — | 18 | 36 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 14 | 5 | 1 | — | 18 | 36 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 6 | 8 | 1 | — | 21 | 35 |
| Lymphoma | D008223 | — | C85.9 | 6 | 8 | 1 | — | 18 | 30 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Head and neck neoplasms | D006258 | — | — | 15 | 11 | — | — | 29 | 54 |
| Glioblastoma | D005909 | EFO_0000515 | — | 18 | 15 | — | — | 20 | 50 |
| Melanoma | D008545 | — | — | 9 | 9 | — | — | 14 | 32 |
| Inflammation | D007249 | MP_0001845 | — | 6 | 8 | — | — | 16 | 29 |
| Hypoxia | D000860 | — | R09.02 | 1 | 6 | — | — | 15 | 22 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 2 | 6 | — | — | 12 | 20 |
| Pick disease of the brain | D020774 | EFO_0003096 | G31.01 | 5 | 2 | — | — | 13 | 20 |
| Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 4 | 3 | — | — | 11 | 18 |
| Frontotemporal dementia | D057180 | — | G31.0 | 8 | 6 | — | — | 4 | 17 |
| Tauopathies | D024801 | — | — | 4 | 4 | — | — | 9 | 17 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Progressive supranuclear palsy | D013494 | EFO_0002512 | G23.1 | 11 | — | — | — | 5 | 16 |
| Transitional cell carcinoma | D002295 | — | — | 5 | — | — | — | 5 | 10 |
| Myocardial infarction | D009203 | EFO_0000612 | I21 | 2 | — | — | — | 8 | 10 |
| Urologic neoplasms | D014571 | — | C64-C68 | 3 | — | — | — | 5 | 8 |
| Hematologic neoplasms | D019337 | — | — | 2 | — | — | — | 6 | 8 |
| Central nervous system neoplasms | D016543 | — | — | 4 | — | — | — | 3 | 7 |
| Meningioma | D008579 | EFO_0003098 | D32.9 | 3 | — | — | — | 3 | 6 |
| Pituitary neoplasms | D010911 | — | — | 2 | — | — | — | 4 | 6 |
| Nervous system diseases | D009422 | — | G00-G99 | 1 | — | — | — | 5 | 6 |
| Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | 4 | — | — | — | 2 | 6 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Papillary thyroid cancer | D000077273 | — | — | — | — | — | — | 8 | 8 |
| Thrombosis | D013927 | — | — | — | — | — | — | 6 | 6 |
| Extranodal nk-t-cell lymphoma | D054391 | — | C86.0 | — | — | — | — | 6 | 6 |
| Mental disorders | D001523 | EFO_0000677 | F91.9 | — | — | — | — | 5 | 5 |
| Infections | D007239 | EFO_0000544 | — | — | — | — | — | 4 | 4 |
| Acute coronary syndrome | D054058 | EFO_0005672 | — | — | — | — | — | 4 | 4 |
| Primary myelofibrosis | D055728 | — | D47.4 | — | — | — | — | 4 | 4 |
| T-cell lymphoma peripheral | D016411 | — | — | — | — | — | — | 4 | 4 |
| T-cell lymphoma | D016399 | — | — | — | — | — | — | 4 | 4 |
| Psychotic disorders | D011618 | — | F20.81 | — | — | — | — | 3 | 3 |
| Drug common name | Fluorodopa f 18 |
| INN | fluorodopa (18f) |
| Description | 6-((18)F)fluoro-L-dopa is a 6-fluoro-L-dopa and a (18)F radiopharmaceutical. |
| Classification | Small molecule |
| Drug class | dopamine receptor agonists |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | N[C@@H](Cc1cc(O)c(O)cc1[18F])C(=O)O |
| PDB | — |
| CAS-ID | 92812-82-3 |
| RxCUI | — |
| ChEMBL ID | CHEMBL3400972 |
| ChEBI ID | 49166 |
| PubChem CID | 56494 |
| DrugBank | DB13848 |
| UNII ID | 2C598205QX (ChemIDplus, GSRS) |

